CRP during pregnancy and in the early postpartum predicted higher weight, body fat, VAT, higher prevalence of the MetS and increased insulin resistance (HOMA-IR, MATSUDA) at 1 year postpartum. This evidence concerns the gene CRP and metabolic syndrome.